FindTrial
Sign In

Attenuation of glycemic and insulin response following tapioca resistant maltodextrin consumption in healthy subjects: A randomized cross-over controlled trial

Attenuation of glycemic and insulin response following tapioca resistant maltodextrin consumption in healthy subjects: A randomized cross-over controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200105004
Enrollment
Unknown
Registered
2020-01-05
Start date
2019-09-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood glucose insulin hunger satiety appetite

Interventions

50 g glucose,50 g tapioca maltodextrin,50 g tapioca resistant maltodextrin,42.5 g TM (85%) + 7.5 g TRM (15%),25 g TM (50%) + 25 g TRM (50%)
Placebo Comparator Dietary Supplement,Experimental Dietary Supplement,Experimental Dietary Supplement,Experimental Dietary Supplement,Experimental Dietary Supplement
GL,TM ,TRM,MIX A ,MIX B

Sponsors

Thailand Research Fund
Lead Sponsor
Banpong Novitat&#44
Collaborator
Co.Ltd
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: aged 18-55 years old, and have fasting plasma glucose below 100 mg/dl.

Exclusion criteria

Exclusion criteria: used any medications/dietary supplements/ insulin injections to lower plasma glucose, or had any allergies to TRM, or smoked or drank alcohol

Design outcomes

Primary

MeasureTime frame
glycemia 0, 30, 60, 120 fasting blood glucose—

Secondary

MeasureTime frame
insulin 0, 30, 60, 120 fasting plasma insulin—

Countries

Thailand

Contacts

Public ContactSuwimol Sapwarobol

Chulalongkorn University

suwimol.sa@chula.ac.th2181116

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026